Cargando…
Knockdown of carboxypeptidase A4 (CPA4) inhibits gastric cancer cell progression via cell cycle arrest and apoptosis
BACKGROUND: Gastric cancer is one of the most prevalent cancers, with a low survival rate at the later stages. Carboxypeptidase A4 (CPA4) is associated with the aggressiveness and growth in cancer. However, its regulatory role in gastric cancer remains unknown. Therefore, we investigated the role of...
Autores principales: | Lei, Xinyi, Liu, Dong, Song, Danjun, Fan, Jun, Dai, Gaiguo, Yang, Litao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830365/ https://www.ncbi.nlm.nih.gov/pubmed/36636089 http://dx.doi.org/10.21037/jgo-22-987 |
Ejemplares similares
-
Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer
por: Bademler, Suleyman, et al.
Publicado: (2019) -
Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4: ANG1-CPA4 axis promotes TNBC progression
por: Liu, Xue, et al.
Publicado: (2023) -
Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas
por: Uhlig, Ria, et al.
Publicado: (2022) -
Novel Carboxypeptidase A6 (CPA6) Mutations Identified in Patients with Juvenile Myoclonic and Generalized Epilepsy
por: Sapio, Matthew R., et al.
Publicado: (2015) -
Knockdown of MRPL42 suppresses glioma cell proliferation by inducing cell cycle arrest and apoptosis
por: Hao, Chunyan, et al.
Publicado: (2018)